Athenex, Inc. Reports Second Quarter Ended June 30, 2020 Financial Results and Provides Corporate Update

NEXT STORY
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
PREV STORY
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Athenex, Inc. Reports Second Quarter Ended June 30, 2020 Financial Results and Provides Corporate Update

NEXT STORY
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
PREV STORY
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Athenex, Inc. Reports Second Quarter Ended June 30, 2020 Financial Results and Provides Corporate Update

NEXT STORY
Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
PREV STORY
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville

author_avatar
NASDAQ Market News

CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News

UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients

author_avatar
NASDAQ Market News